Page last updated: 2024-11-04

sulfasalazine and Leukemia, Myeloid, Acute

sulfasalazine has been researched along with Leukemia, Myeloid, Acute in 2 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research Excerpts

ExcerptRelevanceReference
"One patient was a 14-year-old male with acute myelogenous leukemia who received SCT from a related HLA-identical donor."1.32Experience with the use of salazosulfapyridine for intractable diarrhea after hematopoietic stem cell transplantation. ( Ando, A; Isokawa, S; Miyata, H; Moriguchi, N, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Pardieu, B1
Pasanisi, J1
Ling, F1
Dal Bello, R1
Penneroux, J1
Su, A1
Joudinaud, R1
Chat, L1
Wu, HC1
Duchmann, M1
Sodaro, G1
Chauvel, C1
Castelli, FA1
Vasseur, L1
Pacchiardi, K1
Belloucif, Y1
Laiguillon, MC1
Meduri, E1
Vaganay, C1
Alexe, G1
Berrou, J1
Benaksas, C1
Forget, A1
Braun, T1
Gardin, C1
Raffoux, E1
Clappier, E1
Adès, L1
de Thé, H1
Fenaille, F1
Huntly, BJ1
Stegmaier, K1
Dombret, H1
Fenouille, N1
Lobry, C1
Puissant, A1
Itzykson, R1
Moriguchi, N1
Isokawa, S1
Ando, A1
Miyata, H1

Other Studies

2 other studies available for sulfasalazine and Leukemia, Myeloid, Acute

ArticleYear
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.
    Leukemia, 2022, Volume: 36, Issue:6

    Topics: Cell Line, Tumor; Cysteine; Cystine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Nuclear Protein

2022
Experience with the use of salazosulfapyridine for intractable diarrhea after hematopoietic stem cell transplantation.
    International journal of hematology, 2004, Volume: 80, Issue:5

    Topics: Adolescent; Diarrhea; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immuno

2004